Interferon-free HCV-1 regimen scored high in patients co-infected with HIV

From Internal Medicine News, 24 July 2014: MELBOURNE – A regimen of ABT-450 coformulated with ritonavir, ombitasvir, and dasabuvir, plus ribavirin, resulted in high rates of sustained virologic response in hepatitis C patients co-infected with HIV. Further, the treatment approach did not have a negative effect on HIV viral load. Data from the open-label study, Continue reading Interferon-free HCV-1 regimen scored high in patients co-infected with HIV